IBD Patients Treated With Anti-TNF Drug Develop Skin Lesions

IBD Patients Treated With Anti-TNF Drug Develop Skin Lesions
In a new study, researchers investigated the development of skin lesions and their clinical course in patients with inflammatory bowel disease (IBD) who were under anti-tumor necrosis factor (TNF) antibody therapy. The team reported that although skin lesions are a common side-effect of anti-TNF therapy, their severity status rarely requires discontinuation of treatment. The research

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

2 comments

  1. Craig says:

    I was supposed to start taking a TNF blocker for my CD but with all the dangerous side effects and high cost of the medicine I opted to continue with steroid therapy which most doctors I have talked to said it wouldn’t work for the long term control of the disease. In my case I have been on a lower dose of Prednisone 10 mg Daily now for seven years and I have few side effects from it. I don’t understand why doctors are so quick to prescribe an expensive drug like Remicade that is so dangerous.

    • Sheila Rowan says:

      I would not be here reading this, had it not been for Remicade! I was at death’s door, 18 years ago… it definitely gave my life back! Thankful for research!

Leave a Comment

Your email address will not be published. Required fields are marked *